What is Collate?
Collate is an innovative technology firm specializing in the application of artificial intelligence to automate and simplify the intricate paperwork processes essential for companies operating in the diagnostic, medical device, and drug development sectors. By leveraging advanced AI, Collate provides a comprehensive solution that supports clients throughout their entire product lifecycle, from the initial stages of concept development through to successful market launch. The company's platform is designed to reduce administrative burdens, improve efficiency, and ensure compliance in highly regulated environments.
How much funding has Collate raised?
Collate has raised a total of $30M across 1 funding round:
Angel/Seed
$30M
Angel/Seed (2025): $30M with participation from First Round Capital and Y Combinator
Key Investors in Collate
First Round Capital
First Round Capital is a prominent early-stage venture capital firm known for its support of technology startups, focusing on providing foundational resources and expertise to help companies scale from inception.
Y Combinator
Y Combinator is a highly influential startup accelerator that provides seed funding and mentorship to early-stage companies, playing a critical role in the development and launch of numerous successful technology ventures.
What's next for Collate?
With the infusion of this major strategic investment, Collate is poised for significant growth and further development of its AI-driven solutions. The company is expected to enhance its platform's capabilities, expand its market reach, and potentially explore new verticals within the life sciences ecosystem. This capital injection will likely fuel strategic hiring, bolster research and development efforts, and strengthen its competitive position in the burgeoning market for AI-powered business process automation.
See full Collate company page
